Additional file 15 of Integrated proteogenomic characterization of urothelial carcinoma of the bladder

Additional file 15. Table S3: Differentially expressed mRNAs, proteins, and phosphoproteins between tumors and MNUs. Related to Figure 3, Additional file 3: Fig. S3. A. Lists of mRNAs, proteins, and phosphoproteins used for principal component analysis (PCA). B. Lists of differentially expressed mRNAs, proteins and phosphoproteins (Wilcoxon rank-sum test, FDR < 0.01, Tumors/MNUs ratio > 2 or < 1/2) in tumors and MNUs. C. A list of genes with significant patient survival difference on both protein and mRNA level. D. A list of candidate target genes of UC.

附加文件15，表S3：肿瘤与黏膜正常上皮单位（MNUs）间的差异表达信使RNA（mRNA）、蛋白质及磷酸化蛋白质。本数据集与图3及附加文件3的图S3相关。
A. 用于主成分分析（Principal Component Analysis, PCA）的信使RNA（mRNA）、蛋白质及磷酸化蛋白质列表。
B. 肿瘤与MNUs间的差异表达信使RNA（mRNA）、蛋白质及磷酸化蛋白质列表（采用Wilcoxon秩和检验，错误发现率（False Discovery Rate, FDR）<0.01，肿瘤/MNUs比值>2或<1/2）。
C. 蛋白质与信使RNA（mRNA）水平均存在显著患者生存差异的基因列表。
D. UC候选靶基因列表。